Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$1.59 - $2.7 $36,997 - $62,826
-23,269 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$2.02 - $3.92 $3,308 - $6,420
-1,638 Reduced 6.58%
23,269 $57,000
Q4 2021

Feb 11, 2022

SELL
$3.74 - $6.7 $2,786 - $4,991
-745 Reduced 2.9%
24,907 $93,000
Q3 2021

Nov 12, 2021

SELL
$6.05 - $10.41 $3,684 - $6,339
-609 Reduced 2.32%
25,652 $161,000
Q2 2021

Aug 13, 2021

BUY
$6.66 - $10.92 $14,858 - $24,362
2,231 Added 9.28%
26,261 $259,000
Q1 2021

May 07, 2021

BUY
$4.59 - $18.74 $289 - $1,180
63 Added 0.26%
24,030 $224,000
Q4 2020

Feb 12, 2021

SELL
$3.93 - $5.5 $1,591 - $2,227
-405 Reduced 1.66%
23,967 $115,000
Q3 2020

Nov 04, 2020

SELL
$4.01 - $5.56 $2,221 - $3,080
-554 Reduced 2.22%
24,372 $98,000
Q2 2020

Aug 12, 2020

BUY
$3.0 - $5.52 $1,926 - $3,543
642 Added 2.64%
24,926 $114,000
Q1 2020

May 04, 2020

SELL
$2.54 - $4.75 $3,566 - $6,669
-1,404 Reduced 5.47%
24,284 $79,000
Q4 2019

Feb 05, 2020

BUY
$2.83 - $4.61 $2,210 - $3,600
781 Added 3.14%
25,688 $111,000
Q3 2019

Nov 08, 2019

BUY
$3.83 - $4.72 $2,294 - $2,827
599 Added 2.46%
24,907 $98,000
Q2 2019

Aug 13, 2019

SELL
$3.71 - $4.83 $868 - $1,130
-234 Reduced 0.95%
24,308 $113,000
Q1 2019

May 06, 2019

SELL
$3.2 - $4.19 $2,544 - $3,331
-795 Reduced 3.14%
24,542 $103,000
Q4 2018

Feb 13, 2019

SELL
$2.8 - $4.22 $546 - $822
-195 Reduced 0.76%
25,337 $87,000
Q3 2018

Nov 09, 2018

BUY
$3.5 - $4.91 $1,610 - $2,258
460 Added 1.83%
25,532 $110,000
Q2 2018

Aug 08, 2018

BUY
$3.22 - $4.43 $80,731 - $111,068
25,072 New
25,072 $93,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $372M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.